Respira Therapeutics, Inc. — Form D
Respira Therapeutics, Inc. of ALBUQUERQUE, NM, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-26. The offering totals $9.4M, of which $9.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-04-26
- Form: D
- Accession: 0001704271-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.4M
- Amount sold: $9.1M
- Remaining: $302K
- Investors: 3
- Date of first sale: 2017-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-285508
Issuer
- Name: Respira Therapeutics, Inc.
- CIK: 0001704271
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5901 INDIAN SCHOOL RD NE #107, ALBUQUERQUE, NM, 87110
- Phone: 505-200-9557
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Brian P Birk | Director | Santa Fe, NM |
| David M Blivin | Director | Albuquerque, NM |
| Andrew M Clark | Director | Albuquerque, NM |
| Robert M Curtis | Director | Albuquerque, NM |
| Robert M Curtis | Executive Officer | Albuquerque, NM |
| Matthew P Franklin | Executive Officer | Albuquerque, NM |
More